With supplier issue now resolved, the Minnesota-run medtech company expects to “reach and then exceed” market growth in the ...

Diabetes shines, cardiac ablation stumbles, and new products spark hope--Medtronic's Q2 FY25 shakes up expectations.

Medtronic beat quarterly expectations Tuesday, but Medtronic stock dipped near a sell zone in early trading. Medtronic (MDT) ...

Medtronic lifted the lower end of its annual profit forecast for a second time on Tuesday, banking on sustained demand for ...

Medtronic has reported revenue gains across several of its medical device franchises, leading the company to nudge up its ...

Medtronic — the world's largest medical device company — is preparing for potential new import taxes and other policy changes ...

With its Q2 FY25 results, which beat Street forecasts on Tuesday, Medtronic (NYSE:MDT) narrowed its full-year earnings ...

Tuesday, Medtronic Plc (NYSE:MDT) reported second-quarter 2025 sales of $8.40 billion, beating the consensus of $8.27 billion ...

CEO Geoff Martha said the business did not meet internal growth expectations last quarter due to third-party supply issues ...

Medtronic plc's Q2 earnings show moderate growth, highlighting potential for shareholder value through strategic initiatives. Click for my MDT earnings update.

Medtronic is raising its full-year guidance following second-quarter results that came in ahead of the consensus forecast.

Medtronic lifted the lower end of its annual profit forecast for a second time on Tuesday, banking on sustained demand for ...